Treatment of systemic-onset juvenile arthritis with canakinumab
Joachim Peitz, Gerd Horneff Pediatric Rheumatology Centre, Department of General Pediatrics and Neonatology, Asklepios Clinic, Sankt Augustin, Germany Abstract: Treatment of systemic-onset juvenile idiopathic arthritis is challenging, but the availability of cytokine antagonists targeting interleu...
Guardado en:
Autores principales: | Peitz J, Horneff G |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/974a3e6cbe3c4fa79506ad41d2b57406 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy and Safety of Etanercept Biosimilars Compared With the Originator for Treatment of Juvenile Arthritis: A Prospective Observational Study
por: Franz Thiele, et al.
Publicado: (2021) -
Tocilizumab in the treatment of systemic juvenile idiopathic arthritis
por: Murakami M, et al.
Publicado: (2012) -
Intra-articular corticosteroids in the treatment of juvenile idiopathic arthritis: Safety, efficacy, and features affecting outcome. A comprehensive review of the literature
por: Alisa Carman Gotte
Publicado: (2009) -
New and emerging therapies for the treatment of rheumatoid arthritis
por: Michael G Feely
Publicado: (2010) -
Long-term treatment of rheumatoid arthritis with adalimumab
por: Murdaca G, et al.
Publicado: (2013)